Hypera SA operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hypera SA with three other
pharmaceutical manufacturers in Latin America:
Diagnosticos Da America SA
sales of 3.40 billion Brazilian Reals [US$924.71 million]
of which 100%
was servi os auxiliares),
(2.38 billion Brazilian Reals [US$648.25 million]
of which 84%
was Diagnostic Medicine), and
Genomma Lab Internacional Sab De Cv
based in Mexico
(12.08 billion Mexican Pesos [US$617.09 million]
Hypera SA reported sales of 3.64 billion Brazilian Reals (US$989.77 million)
December of 2017.
increase of 10.6%
versus 2016, when the company's sales were 3.29 billion Brazilian Reals.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Hypera SA had sales
of 3.87 billion Brazilian Reals.